Cell and Gene Therapy

Solvias offers a comprehensive range of orthogonal analytical methods for ATMPs. Our cell and gene therapy building blocks include raw materials testing, cell culture media specific analysis and oligonucleotide analytics. For gene therapies, vector analytics covers the full range of AAV or LV release analytics, including vector aggregation monitoring, sequencing and transfection potency. For cell therapies, our analytical expertise includes cell culture and differentiation mimicking in-life cellular evolutions, process-related impurities testing, recombinant protein expression and functionality determination as well as specific potency assay development. We provide a full complement of release testing to ensure sterility and quality control (QC) for the absence of endotoxins, pyrogens and contamination. We have experience and can support your advanced therapy development from early stage development (e.g. IND application) to commercial testing.